Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

CABA

Cabaletta Bio, Inc. · Healthcare · Biotechnology

3.24 +0.7% mkt cap $528.54M quote delayed (FMP) · as of Aug 26 17:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
10Tracked holders
+2Δ holders
7.88MShares held
$37.20MReported value
+2New positions
−0Exits
Strongly Rising Conviction score 63/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +25.0% · share flow +21.4% · net new positions +20.0%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 67 +17 94.18M $292.87M +24 −6
Q1 2026 49 +1 47.68M $128.08M +7 −6
Q4 2025 47 +1 39.89M $87.37M +1
Q3 2025 15 -1 24.60M $57.56M −1
Q2 2025 13 0 19.37M $29.44M
Q1 2025 10 -1 6.81M $9.44M +2 −3
Q4 2024 11 0 9.36M $21.24M +1 −1
Q3 2024 10 +2 7.88M $37.20M +2
Q2 2024 8 6.49M $48.56M
Holder count
Who holds it · Q3 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Adage Capital Partners 3.04M 0.0% $14.33M 0.0% Held 2 SEC ↗
2 Millennium Management 1.63M +133.3% $7.69M 0.0% ▲ Add 2 SEC ↗
3 Geode Capital Management (passive) 1.09M +12.8% $5.17M 0.0% ▲ Add 2 SEC ↗
4 Geode Capital Management (passive) 1.09M +12.8% $5.17M 0.0% ▲ Add 2 SEC ↗
5 Point72 Asset Management 667.27K New $3.15M 0.0% New 1 SEC ↗
6 T. Rowe Price 552.79K -5.1% $2.61M 0.0% ▼ Trim 2 SEC ↗
7 T. Rowe Price 552.79K -5.1% $2.61M 0.0% ▼ Trim 2 SEC ↗
8 Two Sigma Investments 420.48K +6.3% $1.98M 0.0% ▲ Add 2 SEC ↗
9 Marshall Wace 283.81K -14.1% $1.34M 0.0% ▼ Trim 2 SEC ↗
10 Wellington Management 157.05K -1.1% $741,281 0.0% ▼ Trim 2 SEC ↗
11 Wellington Management 157.05K -1.1% $741,281 0.0% ▼ Trim 2 SEC ↗
12 D. E. Shaw & Co. 33.96K New $160,305 0.0% New 1 SEC ↗
13 D. E. Shaw & Co. 33.96K New $160,305 0.0% New 1 SEC ↗
14 Citadel Advisors 4.51K -98.6% $21,292 0.0% ▼ Trim 2 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Point72 Asset Management $3.15M 0.0%
D. E. Shaw & Co. $160,305 0.0%
D. E. Shaw & Co. $160,305 0.0%

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 107 holders, 84.67M shares, $194.86M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2024 · Methodology · Get this via the API